Exemestane versus anastrozole in postmenopausal women with early breast cancer: NCIC CTG MA.27--a randomized controlled phase III trial (Q36729512)
Jump to navigation
Jump to search
scientific article published on 28 January 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Exemestane versus anastrozole in postmenopausal women with early breast cancer: NCIC CTG MA.27--a randomized controlled phase III trial |
scientific article published on 28 January 2013 |
Statements
Exemestane versus anastrozole in postmenopausal women with early breast cancer: NCIC CTG MA.27--a randomized controlled phase III trial (English)
Vered Stearns
Edith A Perez
George W Sledge
Paul E Goss
Kathleen I Pritchard
Matthew J Ellis
G Thomas Budd
Rafat H Ansari
David B Johnson
Richard Tozer
David P D'Souza
Haji Chalchal
Silvana Spadafora
Pedro E R Liedke
Istvan Lang
Catherine Elliott
Karen A Gelmon
Judy-Anne W Chapman
Lois E Shepherd
28 January 2013
1 reference